Related Experiment Video
Updated: Feb 10, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma
Ming-Hung Hu1,2,3, Tzu-Ting Huang4, Tzu-I Chao5
1Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Background & Aims:
Few molecules are currently verified to be actionable drug targets in cholangiocarcinoma (CCA). Serine/threonine protein phosphatase 5 (PP5) dysregulation is related to several malignancies. However, the role of PP5 in CCA is poorly defined.
Methods:
Colony and tumorsphere formation assays were conducted to establish the role of PP5 in CCA tumorigenesis. Cantharidin (CTD) and norcantharidin (NCTD), both potent PP5 inhibitors, were used in in vitro and in vivo experiments to validate the potential therapeutic role of PP5.
Results:
Increased cell growth, colony formation and tumorsphere formation were observed in PP5-overexpressing CCA cells, whereas PP5 knockdown by shRNA decreased cell growth and colony formation. Tumours from HuCCT1 xenograft-bearing mice treated with PP5-shRNA showed decreased growth and increased AMP-activated protein kinase (AMPK) phosphorylation. Furthermore, CTD treatment decreased cell viability, reduced PP5 activity and enhanced AMPK phosphorylation in CCA cell lines. Overexpressing PP5 or enhancing PP5 activity suppressed AMPK phosphorylation and decreased CTD-induced cell death. Suppressing p-AMPK with siRNA or inhibitors also decreased CTD-induced cell death, suggesting a pivotal role for PP5-AMPK cascades in CCA. Immunoprecipitation revealed that PP5 interacted with AMPK. Importantly, treatment of HuCCT1 xenograft-bearing mice with NCTD, a CTD analogue with a lower systemic toxicity in vivo, suppressed PP5 activity, increased p-AMPK and reduced tumour volume.
Conclusions:
Protein phosphatase 5 negatively regulates AMPK phosphorylation and contributes to CCA aggressiveness; thus, PP5 may be a potential therapeutic target in CCA.
Insights
Protein phosphatase 5 (PP5) promotes cholangiocarcinoma (CCA) growth by inhibiting AMP-activated protein kinase (AMPK). Inhibiting PP5 with compounds like norcantharidin (NCTD) suppressed tumor growth, highlighting PP5 as a potential therapeutic target for CCA.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cholangiocarcinoma (CCA) has limited actionable drug targets.
- Dysregulation of Serine/threonine protein phosphatase 5 (PP5) is implicated in various cancers.
- The specific role of PP5 in CCA pathogenesis remains largely undefined.
Purpose of the Study:
- To investigate the role of PP5 in CCA tumorigenesis.
- To evaluate PP5 inhibitors as a potential therapeutic strategy for CCA.
- To elucidate the molecular mechanisms underlying PP5's function in CCA.
Main Methods:
- Utilized colony and tumorsphere formation assays to assess CCA cell growth.
- Employed PP5 inhibitors Cantharidin (CTD) and norcantharidin (NCTD) in vitro and in vivo.
- Performed PP5 overexpression and knockdown studies, including shRNA-mediated knockdown in xenograft models.
- Investigated the interaction between PP5 and AMP-activated protein kinase (AMPK) via immunoprecipitation.
Main Results:
- PP5 overexpression increased CCA cell growth and colony formation, while PP5 knockdown reduced these.
- PP5 knockdown in xenografts decreased tumor growth and increased AMPK phosphorylation.
- CTD treatment reduced CCA cell viability, PP5 activity, and enhanced AMPK phosphorylation.
- PP5 negatively regulates AMPK phosphorylation; PP5 inhibition or AMPK suppression affected CTD-induced cell death.
- NCTD treatment in vivo suppressed PP5, increased p-AMPK, and reduced tumor volume in CCA xenografts.
Conclusions:
- Protein phosphatase 5 (PP5) negatively regulates AMPK phosphorylation.
- PP5 contributes to CCA aggressiveness and tumorigenesis.
- PP5 represents a promising therapeutic target for cholangiocarcinoma treatment.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
The Resting Membrane Potential
Therapeutic Index

